|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Systematic review of nutrition screening and assessment in inflammatory bowel disease显示文摘BACKGROUND Malnutrition is prevalent in inflammatory bowel disease (IBD). Multiple nutrition screening (NST) and assessment tools (NAT) have been developed for general populations, but the evidence in patients with IBD remains unclear. AIM To systematically review the prevalence of abnormalities on NSTs and NATs, whether NSTs are associated with NATs, and whether they predict clinical outcomes in patients with IBD. METHODS Comprehensive searches performed in Medline, CINAHL Plus and PubMed. Included: English language studies correlating NSTs with NATs or NSTs/NATs with clinical outcomes in IBD. Excluded: Review articles/case studies;use of body mass index/laboratory values as sole NST/NAT;age<16. RESULTS Of 16 studies and 1618 patients were included, 72% Crohn’s disease and 28% ulcerative colitis. Four NSTs (the Malnutrition Universal Screening Tool, Malnutrition Inflammation Risk Tool (MIRT), Saskatchewan Inflammatory Bowel Disease Nutrition Risk Tool (SaskIBD-NRT) and Nutrition Risk Screening 2002 (NRS-2002) were significantly associated with nutritional assessment measures of sarcopenia and the Subjective Global Assessment (SGA). Three NSTs (MIRT, NRS-2002 and Nutritional Risk Index) were associated with clinical outcomes including hospitalizations, need for surgery, disease flares, and length of stay (LOS). Sarcopenia was the most commonly evaluated NAT associated with outcomes including the need for surgery and post-operative complications. The SGA was not associated with clinical outcomes aside from LOS. CONCLUSION There is limited evidence correlating NSTs, NATs and clinical outcomes in IBD. Although studies support the association of NSTs/NATs with relevant outcomes, the heterogeneity calls for further studies before an optimal tool can be recommended. The NRS-2002, measures of sarcopenia and developments of novel NSTs/NATs, such as the MIRT, represent key, clinically-relevant areas for future exploration. | Suqing Li Michael Ney Tannaz Eslamparast Ben Vandermeer Kathleen P Ismond Karen Kroeker Brendan Halloran Maitreyi Raman Puneeta Tandon | 2019 | World Journal of Gastroenterology2019，25，28： | 9 |
| 2 | 肝硬化患者静脉曲张性出血与非静脉曲张性出血临床结局的比较显示文摘【据《J Gastroenterol Hepatol》2018年3月报道】题:肝硬化患者静脉曲张性出血与非静脉曲张性出血临床结局的比较(作者Tandon P等)
急性上消化道出血(UGIB)在肝硬化患者中有着显著的发病率和死亡率。其可分为急性静脉曲张性出血(AVB)或非静脉曲张性出血(NVB)。死亡率、住院时间(LOS)和30d再入院的差异尚待确定。苓研究旨在评估因UGIB住院的肝硬化患者在上述临床结局方面的差异。 | Tandon P 谢智钦 刘智勇 邓飞杰 | 2018 | 临床肝胆病杂志2018，34，5： | 3 |
| 3 | Crystallization behavior of nparaffins in Bombay-High middle-distillate wax/gel显示文摘 | Srivastava S P Tandon R S Verma P S | 1992 | Fuel1992，71，5： | 1 |
| 4 | Study of 3D micro-ultrasonic machining显示文摘 | Yu Zuyuan Rajurkar K P Tandon A | | 0，，04： | 1 |
| 5 | Angiographic embolization for intractable obstetrical bleeding显示文摘 | Tandon P Juneja SK Mohan B | 2014 | Int J Appl Basic Med Res2014，4，1： | 1 |
| 6 | Neuro protective effects of brain derived neuro trophic afctor in seizures during development显示文摘 | Tandon P Yang Y Das K | 1999 | Neuro Science1999，91，1： | 1 |
| 7 | Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency显示文摘 | Tandon P Gallo CA Khatri S | 2011 | Proc Natl Acad Sci USA2011，108，6： | 1 |
| 8 | Perioperative complications of intraventricular neuroendoscopy: a 7-year experience 显示文摘 | Ganjoo P Sethi S Tandon MS | 2010 | Turk Neurosurg2010，20，1： | 1 |
| 9 | Evaluation of the activity of 16 me- dicinal plants against Neisseria gonorrhoeae 显示文摘 | SHOKEEN P BALA M TANDON V | 2009 | International Journal of Antimicrobial Agents2009，33，1： | 1 |
| 10 | 显示文摘 | Suri K Annapoorni S Tandon R P | 2002 | Synthetic Metals2002，126，： | 1 |
| 11 | Bacterial infections, sepsis, and multior- gan failure in cirrhosis显示文摘 | Tandon P Garcia-Tsao G | 2008 | Semin Liver Dis2008，28，1： | 1 |
| 12 | Three dimensional modeling and finite element simulation of a generic'end mill显示文摘 | Tandon P Rajik Khan M | 2009 | Computer-Aided Design2009，41，2： | 1 |
| 13 | Innovation,Market Structure,and Welfare显示文摘 | Tandon P | 1984 | American Economic Review1984，74，39： | 1 |
| 14 | Medicahreatmentofbleedingpepticulcerolddrugs, newregiments 显示文摘 | Arora A Tandon P K | 1991 | Gut1991，32，11： | 1 |
| 15 | Pelvic Tuberculosis mimic- king advanced ovarian malignancy 显示文摘 | DEVI L TANDON R GOEL P | 2012 | Trop Doct2012，42，： | 1 |
| 16 | Three dimensional modeling and finite element simulation of a generic end mill显示文摘 | Tandon P Rajik K M | | 0，，02： | 1 |
| 17 | Functional status of auditory pathways in hypothyroidism: evoked potential study显示文摘 | Anjana Y Vaney N Tandon O P | 2006 | Indian J Physiol Pharmacol2006，50，4： | 1 |
| 18 | Measure-ment of portal pressure显示文摘 | ABRALDES JG SARLIEVE P TANDON P | 2014 | Clin Liver Dis2014，18，4： | 1 |
| 19 | Monte Carlo simulation of particleaggregation and simultaneous restructuring显示文摘 | Tandon P Rosner D E | 1999 | Journal ofColloid and Interface Science1999，213，2： | 1 |
| 20 | Acute effects of MK-801 on kainic acid-induced seizures in neuronatal rats 显示文摘 | Stafstrom CE Tandon P Hori A | 1997 | Epilepsy Res1997，26，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员